StemCyte has officially announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long...
For drug developers working on oral solid dosage drug projects, solubility, and therefore bioavailability, is a significant challenge. At present, poor water solubility impacts...
The US Food and Drug Administration has formally approved Merck’s WINREVAIR therapeutic for the treatment of adults with pulmonary arterial hypertension (PAH). Understood to...